Paragon 28 Maintains Growth Pace Despite Supply Pinch

Paragon 28 reported 2Q23 orthopedic sales of $51 million, +20% compared to the second quarter of 2022. The company generated $103 million in sales for the first half of 2023, +22.9% compared to the prior year period.

Since going public, Paragon 28 has grown at multiples of the overall foot and ankle market. The company launched 20 new...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

ME

Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.



Contact Us

0